Related Experiment Video
Updated: Aug 8, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
"Authors' Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2
1Department of Pediatrics, Indira Gandhi Medical College, Shimla, Himachal Pradesh 171001 India.
Insights
Multisystem inflammatory syndrome in children (MIS-C) cases are rising globally with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. This review shares early pandemic findings to aid MIS-C management strategies and guidelines.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- The global rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has led to an increase in pediatric cases of multisystem inflammatory syndrome (MIS-C).
- Early pandemic experiences and evidence regarding MIS-C are crucial for understanding and managing this condition in children.
- This review consolidates emerging findings and clinical experiences during the initial phase of the pandemic.
Discussion:
- Multisystem inflammatory syndrome in children (MIS-C) presents a significant post-infectious complication of SARS-CoV-2.
- Understanding the pathophysiology and clinical spectrum of MIS-C is vital for timely diagnosis and intervention.
- The review highlights the importance of a multidisciplinary approach to MIS-C patient care.
Key Insights:
- Increased incidence of MIS-C observed globally in pediatric populations following SARS-CoV-2 outbreaks.
- Early identification of MIS-C symptoms and prompt treatment are associated with better patient outcomes.
- Evidence-based findings from the early pandemic phase provide foundational knowledge for MIS-C management.
Outlook:
- Further research is needed to elucidate the long-term effects of MIS-C on children's health.
- Development of standardized diagnostic criteria and treatment protocols for MIS-C is essential.
- International collaboration will be key in refining global strategies for managing MIS-C and future pediatric inflammatory syndromes.
Abstract:
With increased patients of severe acute respiratory syndrome coronavirus 2 infection, more children with multisystem inflammatory syndrome (MIS-C) are being reported worldwide. Our focus is to share the new evidence-based findings and experiences during the early stage of the pandemic with the researchers on a larger platform . We hope this review will help to frame appropriate strategies and guidelines for management of MIS-C.
More Related Videos
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Coronavirus
Respiratory Syncytial Virus Disease